Semaglutide is a GLP-1 analogue with 94% sequence as same as human GLP-1. Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP- receptor. GLP-1 is a physiological regulator of appetite and caloric intake. It is also present in several areas of brain that involved in appetite regulation. Semaglutide lowers body weight through decreased calorie intake and by an overall reduced appetite. It also stimulates insulin secretion and reduces glucagon secretion in a glucose dependent manner.
FITARO 1.7MG INJECTION
$39.50
| Form | Injection |
| Packaging Type | Vial |
| Brand | FITARO 1.7 INJECTION |
| Packaging Size | 1 INJECTION |
| Manufacturer | INCEPTA PHARACEUTICAL LT |
| Usage / Application | Clinical |
